Consolidation for ovarian cancer in remission

J Clin Oncol. 2006 Feb 1;24(4):537-9. doi: 10.1200/JCO.2005.04.5138.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • CA-125 Antigen / drug effects
  • CA-125 Antigen / isolation & purification
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Membrane Proteins
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / immunology
  • Ovarian Neoplasms / surgery*
  • Randomized Controlled Trials as Topic
  • Remission Induction
  • Survival Analysis
  • Treatment Outcome
  • Yttrium Radioisotopes

Substances

  • Antibodies, Monoclonal
  • CA-125 Antigen
  • MUC16 protein, human
  • Membrane Proteins
  • Yttrium Radioisotopes
  • pemtumomab